ALTEOGEN
₩259,500.00Change from previous close: −2.08%Absolute change: −₩5,500.00
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- ₩18.05T
- Enterprise value
- ₩17.74T
- Forward P/E
- 48.0
- Price/sales
- 71.1
- EV/EBITDA
- 136.7
- EV/revenue
- 69.8
Profitability and growth
- Gross margin
- 80.9%
- Operating margin
- 49.6%
- Net margin
- 75.5%
- ROE
- 35.6%
- ROA
- 11.2%
- Revenue growth (year over year)
- 269.5%
Financial health
- Total cash
- ₩446.84B
- Total debt
- ₩7.01B
- Debt/equity
- 0.01
- Current ratio
- 5.73
- Quick ratio
- 5.10
Dividends
- Annual dividend per share
- ₩285.38
- Dividend yield
- 0.1%
- Payout ratio
- 10.9%
- Ex-dividend date
- December 29, 2025
Analysts and estimates
- Average price target
- ₩405,512.80
- Median price target
- ₩410,000.00
- High price target
- ₩520,000.00
- Low price target
- ₩310,000.00
- Analysts with a price target
- 6
- EPS estimate, current year
- ₩4,394.21
Shares and trading
- Beta
- 1.00
- Average volume
- 550.96K
- Shares outstanding
- 69.56M
- Float
- 52.05M
- Institutional ownership
- 19.2%
- Insider ownership
- 25.5%